Does NIVOLUMAB Cause Vitiligo? 229 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 229 reports of Vitiligo have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.3% of all adverse event reports for NIVOLUMAB.
229
Reports of Vitiligo with NIVOLUMAB
0.3%
of all NIVOLUMAB reports
11
Deaths
61
Hospitalizations
How Dangerous Is Vitiligo From NIVOLUMAB?
Of the 229 reports, 11 (4.8%) resulted in death, 61 (26.6%) required hospitalization, and 13 (5.7%) were considered life-threatening.
Is Vitiligo Listed in the Official Label?
Yes, Vitiligo is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Vitiligo?
PEMBROLIZUMAB (199)
RUXOLITINIB (157)
IPILIMUMAB (146)
DUPILUMAB (112)
RIBOCICLIB (102)
ADALIMUMAB (83)
LETROZOLE (55)
SECUKINUMAB (52)
METHOTREXATE (48)
INFLIXIMAB (45)
Which NIVOLUMAB Alternatives Have Lower Vitiligo Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE